pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

HCA Healthcare sues Independence Blue Cross over $345,000 in unpaid Texas hospital claims

Sep 18, 2026·read at STAT ↗RegulatoryNegative

Several Texas hospitals owned by HCA Healthcare have filed a lawsuit against Independence Blue Cross, a Philadelphia‑based insurer, seeking more than $345,000 in unpaid medical claims dating back roughly four years.

The case highlights ongoing disputes over prior authorizations and how insurers determine medical necessity. HCA argues that the insurer’s denial of claims reflects inconsistent standards that can delay or deny needed care.

Industry observers note that the lawsuit also sheds light on the high prices hospitals charge insurers and the broader tension between cost‑containment measures and provider reimbursement.

The legal battle underscores the friction between large for‑profit hospital systems and Blue Cross Blue Shield plans as they navigate the complex landscape of health‑care payments and authorization policies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: In a fight over denied claims, HCA sues out-of-state Blue Cross Blue Shield plan”

read at STAT ↗
542 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
GLP-1 receptor

related stories

  • May 18Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugBioPharma Dive
  • May 18STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much moreSTAT
  • May 15FDA hold puts Aardvark Prader-Willi drug in limboBioPharma Dive
  • May 15India’s pharma industry is going global. But can it catch up to China?BioPharma Dive
  • May 14Dr Jones on the Protective Benefit and Tolerability of GLP-1 Agonists vs Aspirin for CRC Preventiononclive